Germano Ferreira

Roche (Switzerland) — Switzerland

Medicine · Health Sciences

14h-index947citations41works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Myeloid Leukemia Treatments(10), Hepatitis C virus research(4), Influenza Virus Research Studies(4), Hepatitis B Virus Studies(4), Chronic Lymphocytic Leukemia Research(4)

Publications41 total

Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab
Neurology Neuroimmunology & Neuroinflammation·2024· 21 citedOpen Access
176. Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Approximately 4,000 Pregnancies To Date
Multiple Sclerosis and Related Disorders·2024· 2 cited
The Oncogenic ΔNp73α Isoform Contributes to Aggressiveness in APL By Leading to ATRA Resistance through NANOG/BMP4 Axis Upregulation
Blood·2024
Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States
Clinical Lymphoma Myeloma & Leukemia·2024· 5 cited
CML-619 Adverse Events (AEs) Among Patients With Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitors and Subsequent Treatment Adjustment: A Large US Commercial Claims Database Analysis
Clinical Lymphoma Myeloma & Leukemia·2024
Adverse Events (AEs) Among Patients With Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitors and Subsequent Treatment Adjustment: A Large US Commercial Claims Database Analysis
Clinical Lymphoma Myeloma & Leukemia·2024
CML-317 Asciminib After Two or More Prior Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Real-World Evaluation of Treatment Patterns and Clinical Outcomes in US Clinical Practice
Clinical Lymphoma Myeloma & Leukemia·2024
Asciminib After Two or More Prior Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Real-World Evaluation of Treatment Patterns and Clinical Outcomes in US Clinical Practice
Clinical Lymphoma Myeloma & Leukemia·2024
Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004)
Neurology·2024· 2 cited
Pregnancy and Infant Outcomes in Women Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of the Largest Available Outcomes Database
Multiple Sclerosis and Related Disorders·2023· 7 cited
Fracionamento de seringas intravítreas de aflibercept e ranibizumab, utilizando técnica assética
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)·2023Open Access
Real-World Effectiveness of Asciminib in Patients with Chronic Myeloid Leukemia (CML) Harboring the T315I Mutation: A Global Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)
Blood·2023· 3 cited
Real-World Evaluation of Treatment Patterns and Clinical Outcomes Among Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Asciminib in US Clinical Practice
Blood·2023Open Access
Effectiveness of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after Two or More Prior Tyrosine Kinase Inhibitors
Blood·2022
Real-World Usage of Asciminib in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) in the United States (US) Using a Large Claims Database
Blood·2022· 1 cited
O papel do fisioterapeuta na pandemia por SARS-CoV-2
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)·2022· 2 citedOpen Access
Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Third Line of TKI Therapy and Beyond Based on Real-World Evidence
Blood·2021· 2 cited
Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence
Pharmacoepidemiology and Drug Safety·2020· 26 citedOpen Access
Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink
European Journal of Gastroenterology & Hepatology·2019· 10 citedOpen Access
The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review
Expert Review of Vaccines·2019· 35 cited
page 1 of 3Next →

Frequent Co-authors

Andrea Damon(7), Kejal Jadhav(7), Thomas Verstraeten(5), Catherine Cohet(5), David Wei(5), Kaatje Bollaerts(4), Gaël Dos Santos(4), Vivek Shinde(4), Dominique Rosillon(4), Sandra Vukusic(4), Riley Bove(4), Ruth Dobson(4), Thomas F. McElrath(4), Celia Oreja‐Guevara(4), Carlo Pietrasanta(4), Licínio Craveiro(4), Noemi Pasquarelli(4), Kerstin Hellwig(4), Ehab Atallah(4), Dominick Latrémouille-Viau(4)